Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 57.90K | 48.20K | 54.10K | 98.70K | 122.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 57.90K | 48.20K | 54.10K | 98.70K | 122.10K |
| Cost of Revenue | 25.30K | 29.20K | 66.00K | 34.10K | 58.70K |
| Gross Profit | 32.60K | 19.00K | -11.90K | 64.60K | 63.40K |
| SG&A Expenses | 468.10K | 398.20K | 454.00K | 420.70K | 354.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 493.40K | 427.50K | 520.00K | 454.80K | 412.70K |
| Operating Income | -435.50K | -379.20K | -465.90K | -356.10K | -290.50K |
| Income Before Tax | -3.95M | -459.70K | -488.50K | -523.50K | 369.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.95M | -459.70K | -488.50K | -523.50K | 369.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.95M | -459.70K | -488.50K | -523.50K | 369.60K |
| EBIT | -435.50K | -379.20K | -465.90K | -356.10K | -290.50K |
| EBITDA | -433.10K | -376.70K | -463.30K | -353.30K | -287.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 8.07B | 8.01B | 7.88B | 7.82B | 7.74B |
| Average Diluted Shares Outstanding | 8.07B | 8.01B | 7.88B | 7.82B | 37.73B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |